Literature DB >> 33763469

Mechanisms of Trx2/ASK1-Mediated Mitochondrial Injury in Pemphigus Vulgaris.

Bin Wei1, Fenghe Li2.   

Abstract

OBJECTIVE: Apoptotic events mediated by mitochondrial injury play an important role on the onset of Pemphigus vulgaris (PV). The thioredoxin-2 (Trx2)/apoptosis signal-regulating kinase 1 (ASK1) signaling pathway is considered a key cascade involved on the regulation of mitochondrial injury. Hence, we have investigated the regulatory mechanism of the Trx2/ASK1 signaling in PV-induced mitochondrial injury.
METHODS: Serum and tissue samples were collected from clinical PV patients to detect the oxidative stress factors, cell apoptosis, and expression of members from Trx2/ASK1 signaling. HaCaT cells were cultured with the serum of PV patients and transfected with Trx2 overexpression or silencing vector. Changes in the levels of reactive oxygen species (ROS), mitochondrial membrane potential (△ψm), and apoptosis were further evaluated. A PV mouse model was established and administered with Trx2-overexpressing plasmid. The effect of ectopic Trx2 expression towards acantholysis in PV mice was observed.
RESULTS: A series of cellular and molecular effects, including (i) increased levels of oxidative stress products, (ii) destruction of epithelial cells in the skin tissues, (iii) induction of apoptosis in keratinocytes, (iv) reduction of Trx2 protein levels, and (v) enhanced phosphorylation of ASK1, were detected in PV patients. In vitro experiments confirmed that Trx2 can inhibit ASK1 phosphorylation, alleviate ROS release, decrease △ψm, and lower the apoptotic rate. Injection of Trx2-overexpressing vectors in vivo could also relieve acantholysis and blister formation in PV mice.
CONCLUSION: The Trx2/ASK1 signaling pathway regulates the incidence of PV mediated by mitochondrial injury.
Copyright © 2021 Bin Wei and Fenghe Li.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33763469      PMCID: PMC7946479          DOI: 10.1155/2021/2471518

Source DB:  PubMed          Journal:  Biomed Res Int            Impact factor:   3.411


  20 in total

Review 1.  Pemphigus.

Authors:  Michael Kasperkiewicz; Christoph T Ellebrecht; Hayato Takahashi; Jun Yamagami; Detlef Zillikens; Aimee S Payne; Masayuki Amagai
Journal:  Nat Rev Dis Primers       Date:  2017-05-11       Impact factor: 52.329

2.  Pemphigus vulgaris antibodies target the mitochondrial nicotinic acetylcholine receptors that protect keratinocytes from apoptolysis.

Authors:  Alex Chernyavsky; Yumay Chen; Ping H Wang; Sergei A Grando
Journal:  Int Immunopharmacol       Date:  2015-05-18       Impact factor: 4.932

3.  Naringenin protects keratinocytes from oxidative stress injury via inhibition of the NOD2-mediated NF-κB pathway in pemphigus vulgaris.

Authors:  Junqin Liang; Yilinuer Halipu; Fengxia Hu; Buwajieer Yakeya; Wenjing Chen; Huan Zhang; Xiaojing Kang
Journal:  Biomed Pharmacother       Date:  2017-06-04       Impact factor: 6.529

4.  ASK1 contributes to fibrosis and dysfunction in models of kidney disease.

Authors:  John T Liles; Britton K Corkey; Gregory T Notte; Grant R Budas; Eric B Lansdon; Ford Hinojosa-Kirschenbaum; Shawn S Badal; Michael Lee; Brian E Schultz; Sarah Wise; Swetha Pendem; Michael Graupe; Laurie Castonguay; Keith A Koch; Melanie H Wong; Giuseppe A Papalia; Dorothy M French; Theodore Sullivan; Erik G Huntzicker; Frank Y Ma; David J Nikolic-Paterson; Tareq Altuhaifi; Haichun Yang; Agnes B Fogo; David G Breckenridge
Journal:  J Clin Invest       Date:  2018-07-19       Impact factor: 14.808

5.  Detailed profiling of anti-desmoglein autoantibodies identifies anti-Dsg1 reactivity as a key driver of disease activity and clinical expression in pemphigus vulgaris.

Authors:  S Y Naseer; K Seiffert-Sinha; A A Sinha
Journal:  Autoimmunity       Date:  2014-11-11       Impact factor: 2.815

Review 6.  Urban legends: pemphigus vulgaris.

Authors:  N Cirillo; E Cozzani; M Carrozzo; S A Grando
Journal:  Oral Dis       Date:  2012-02-15       Impact factor: 3.511

7.  Comparison between the efficacy of intralesional rituximab versus intralesional triamcinolone in the treatment refractory Pemphigus Vulgaris lesions: A randomized clinical trial.

Authors:  Fariba Iraji; Farzaneh Danesh; Gita Faghihi; Amirhossein Siadat; Fatemeh Mokhtari; Mahboobeh Talakoob; Hossein Hafezi
Journal:  Int Immunopharmacol       Date:  2019-05-10       Impact factor: 4.932

8.  Early response of glutathione- and thioredoxin-dependent antioxidant defense systems to Tl(I)- and Tl(III)-mediated oxidative stress in adherent pheochromocytoma (PC12adh) cells.

Authors:  Lis C Puga Molina; Damiana M Salvatierra Fréchou; Sandra V Verstraeten
Journal:  Arch Toxicol       Date:  2017-09-02       Impact factor: 5.153

9.  Pemphigus vulgaris autoantibody profiling by proteomic technique.

Authors:  Mina Kalantari-Dehaghi; Grant J Anhalt; Michael J Camilleri; Alex I Chernyavsky; Sookhee Chun; Philip L Felgner; Algis Jasinskas; Kristin M Leiferman; Li Liang; Steve Marchenko; Rie Nakajima-Sasaki; Mark R Pittelkow; John J Zone; Sergei A Grando
Journal:  PLoS One       Date:  2013-03-07       Impact factor: 3.240

Review 10.  Management of Pemphigus Vulgaris.

Authors:  Mimansa Cholera; Nita Chainani-Wu
Journal:  Adv Ther       Date:  2016-06-10       Impact factor: 3.845

View more
  3 in total

Review 1.  The Thioredoxin System of Mammalian Cells and Its Modulators.

Authors:  Aseel Ali Hasan; Elena Kalinina; Victor Tatarskiy; Alexander Shtil
Journal:  Biomedicines       Date:  2022-07-21

Review 2.  Mitochondrial Autoantibodies and the Role of Apoptosis in Pemphigus Vulgaris.

Authors:  Dana M Hutchison; Anna-Marie Hosking; Ellen M Hong; Sergei A Grando
Journal:  Antibodies (Basel)       Date:  2022-08-25

Review 3.  What protein kinases are crucial for acantholysis and blister formation in pemphigus vulgaris? A systematic review.

Authors:  Adriano Brescacin; Zunaira Baig; Jaspreet Bhinder; Sen Lin; Lovejot Brar; Nicola Cirillo
Journal:  J Cell Physiol       Date:  2022-05-26       Impact factor: 6.513

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.